What does the evidence say about Iron Sleep Quality Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Iron Sleep Quality Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - However, the evidence base for TCM pharmacologic interventions in hemodialysis-related RLS remains unclear. [Zhang J (2026); evidence level 1] - Pharmacologic therapy significantly improved IRLS scores (MD -7.84), sleep quality (SMD -0.82), and quality of life (SMD 0.48). [Zhang J (2026); evidence level 1] - A heatmap further revealed that dopaminergic agents were associated with the highest frequency of adverse events, particularly nausea, hypotension, and augmentation. [Zhang J (2026); evidence level 1] - Background Restless Legs Syndrome (RLS) is highly prevalent among adults receiving maintenance hemodialysis and significantly impairs sleep, psychological well-being, and quality of life. [Zhang J (2026); evidence level 1] - 1 4 5 1 4 5 Recent investigations in this field have improved our mechanistic understanding on RLS, with evidence implicating dopaminergic dysfunction, brain iron deficiency, and additional signaling pathways that may affect sensory symptoms and motor hyperexcitability (,). [Liu Rujia (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.